CELVIA CC AS
Desconocido
ARTVOC: Volatolomic approaches for improving success rates in assisted reproductive technology
CELVIA CC AS
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2022-SE-01
Volatolomics has emerged as a new frontier in deciphering unreached matters related with health conditions. Volatolomics research is based o...
2023-10-03 - 2027-09-30 | Financiado
2023-10-03 - 2027-09-30 | Financiado
HEPINIB: Heparanase inhibition as a multifunctional targeting approach in cancer
CELVIA CC AS
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2021-SE-01
Cancer is a leading cause of mortality within the aging European population. Therapeutic targeting is hampered by the complexity of the dise...
2022-10-28 - 2026-12-31 | Financiado
2022-10-28 - 2026-12-31 | Financiado
TRENDO: Translational Research on Endometriosis
CELVIA CC AS
participó en un
H2020:
H2020-MSCA-RISE-2020
Endometriosis is a sever disease affecting 10% of reproductive age women, characterized by the presence of endometrial-like tissue outside o...
2020-10-05 - 2025-07-31 | Financiado
2020-10-05 - 2025-07-31 | Financiado
HUTER: HUMAN UTERUS CELL ATLAS
CELVIA CC AS
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The Human Uterus Cell Atlas (HUTER) project aims to create the single-cell and spatial reference map of the human uterus. HUTER project will...
2019-12-06 - 2022-06-30 | Financiado
2019-12-06 - 2022-06-30 | Financiado
MATER: Innovative Training Network in Female Reproductive Care
CELVIA CC AS
participó en un
H2020:
H2020-MSCA-ITN-2018
MATER consortium will establish Innovative Training Network (ITN) of five academia and five industry partners from 7 European countries with...
2019-09-13 - 2024-03-31 | Financiado
2019-09-13 - 2024-03-31 | Financiado
FREIA: Female Reproductive toxicity of EDCs a human evidence based screening and Identification Approach
CELVIA CC AS
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The FREIA consortium aims to close gaps in scientific knowledge on the mechanisms by which EDCs can affect female reproduction during specif...
2018-12-03 - 2024-06-30 | Financiado
2018-12-03 - 2024-06-30 | Financiado
MOMENDO: Molecular Mechanisms of Endometriosis
CELVIA CC AS
participó en un
H2020:
H2020-MSCA-RISE-2015
Endometriosis (the presence of endometrial-like tissue or ‘lesions’ outside the uterus) is a chronic inflammatory disease affecting 6-10% of...
2015-11-04 - 2019-12-31 | Financiado
2015-11-04 - 2019-12-31 | Financiado
SARM: Endometrial and embryonic genomics searching for biomarkers in assisted reproduction short title...
CELVIA CC AS
tramitó un
FP7:
Infertility is a serious medical concern preventing the parenthood in 10% of couples. Infertility treatment using assisted reproduction tech...
Financiado
Financiado
* No se disponen de datos de la empresa actual.